Literature DB >> 12737196

Efficacy of an inactivated canine coronavirus vaccine in pups.

A Pratelli1, A Tinelli, N Decaro, F Cirone, G Elia, S Roperto, M Tempesta, C Buonavoglia.   

Abstract

The efficacy of an inactivated CCoV vaccine (Duramune PC) was evaluated in four pups. Two dogs were maintained non-vaccinated. Ten days after the booster shot all the pups were challenged with a field CCoV strain administered by oro-nasal route. The vaccinated pups did not display clinical signs and shed the challenge-virus for 11.25 days, evaluated by virus isolation, and 13.5 days, evaluated by PCR assay. The two non vaccinated pups displayed mild diarrhoea at day post-challenge 4 and shed the challenge-virus for 14 and 15 days respectively, by virus isolation, and for 22 and 24 days respectively, by PCR assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737196

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  18 in total

1.  Fecal immunoglobulin A antibodies in dogs infected or vaccinated with canine coronavirus.

Authors:  Nicola Decaro; Annamaria Pratelli; Antonella Tinelli; Vito Martella; Michele Camero; Domenico Buonavoglia; Maria Tempesta; Anna Maria Caroli; Canio Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 2.  Molecular mechanisms of severe acute respiratory syndrome (SARS).

Authors:  David A Groneberg; Rolf Hilgenfeld; Peter Zabel
Journal:  Respir Res       Date:  2005-01-20

3.  Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

Authors:  Noton Kumar Dutta; Kaushiki Mazumdar; Byoung-Hee Lee; Min-Won Baek; Dong-Jae Kim; Yi-Rang Na; Sung-Hoon Park; Hyun-Kyoung Lee; Hiroaki Kariwa; Le Quynh Mai; Jae-Hak Park
Journal:  Immunol Lett       Date:  2008-04-08       Impact factor: 3.685

4.  COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us.

Authors:  Nicola Decaro; Vito Martella; Linda J Saif; Canio Buonavoglia
Journal:  Res Vet Sci       Date:  2020-04-07       Impact factor: 2.534

5.  Recommendations on vaccination for Latin American small animal practitioners: a report of the WSAVA Vaccination Guidelines Group.

Authors:  M J Day; C Crawford; M Marcondes; R A Squires
Journal:  J Small Anim Pract       Date:  2020-03-30       Impact factor: 1.522

6.  Co-Circulation of Canine Coronavirus I and IIa/b with High Prevalence and Genetic Diversity in Heilongjiang Province, Northeast China.

Authors:  Xinyu Wang; Chunqiu Li; Donghua Guo; Xinyu Wang; Shan Wei; Yufei Geng; Enyu Wang; Zhihui Wang; Xiwen Zhao; Mingjun Su; Qiujin Liu; Siyao Zhang; Li Feng; Dongbo Sun
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

7.  Cloning and expression of two fragments of the S gene of canine coronavirus type I.

Authors:  Annamaria Pratelli; Gabriella Elia; Nicola Decaro; Sebastiana Tola; Antonella Tinelli; Vito Martella; Stefano Rocca; Maria Tempesta; Canio Buonavoglia
Journal:  J Virol Methods       Date:  2004-04       Impact factor: 2.014

8.  Quantitation of canine coronavirus RNA in the faeces of dogs by TaqMan RT-PCR.

Authors:  Nicola Decaro; Annamaria Pratelli; Marco Campolo; Gabriella Elia; Vito Martella; Maria Tempesta; Canio Buonavoglia
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

9.  Immunogenicity of SARS inactivated vaccine in BALB/c mice.

Authors:  Sheng Xiong; Yi-Fei Wang; Mei-Ying Zhang; Xin-Jian Liu; Chuan-Hai Zhang; Shi-Sheng Liu; Chui-Wen Qian; Jiu-Xiang Li; Jia-Hai Lu; Zhuo-Yue Wan; Huan-Yin Zheng; Xin-Ge Yan; Min-Jie Meng; Jiang-lin Fan
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

10.  A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

Authors:  Naomi Takasuka; Hideki Fujii; Yoshimasa Takahashi; Masataka Kasai; Shigeru Morikawa; Shigeyuki Itamura; Koji Ishii; Masahiro Sakaguchi; Kazuo Ohnishi; Masamichi Ohshima; Shu-ichi Hashimoto; Takato Odagiri; Masato Tashiro; Hiroshi Yoshikura; Toshitada Takemori; Yasuko Tsunetsugu-Yokota
Journal:  Int Immunol       Date:  2004-08-16       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.